StreetAlpha
13F holdings · Q3 2026

M28 Capital Management

Stamford, CT · files as M28 Capital Management LP
Know the moment M28 Capital Management filesYou follow M28 Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1807489

M28 Capital Management reported 9 stocks worth $36M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are WVE (47.1%), IVVD (22.3%) and TGTX (13.7%). Compared with Q2 2026, the fund opened new positions in WVE and CRIS and sold out of WVE and CRIS.

Latest filing: what M28 Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
2 new0 added0 trimmed2 sold outBought about $17M · sold about $26.8M
New 2
Added 0

None

Trimmed 0

None

Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$36M−23.6% vs last quarter
Stocks held92 new · 2 sold out
Top 5 weight92.9%very concentrated
Turnover122%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
WVE
Wave Life Sciences Inc.
$17M47.1%4.6MNew position1 of 8
2
IVVD
Invivyd Inc
$8M22.3%9.2MNo change8 of 8
3
TGTX
TG Therapeutics Inc
$4.9M13.7%88KNo change8 of 8
4
ARWR
Arrowhead Pharmaceuticals in
$2.4M6.7%37KNo change8 of 8
5
SLN
Silence Therapeutics PLC
$1.1M3.1%101KNo change8 of 8
6
GUTS
Fractyl Health Inc
$1M2.8%1.9MNo change8 of 8
7
PRQR
Proqr Thrapeutics N V
$996K2.8%600KNo change8 of 8
8
RCKT
Rocket Pharmaceuticals Inc
$555K1.5%211KNo change8 of 8
9
CRIS
Curis Inc
$12K0.0%14KNew position1 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
WVE
Wave Life Sciences Ltd
$26.7M4.6M
CRIS
Curis Inc
$149K285K

Reported value

last 8 quarters
$102MQ4 '24
$73MQ1 '25
$58.6MQ2 '25
$68MQ3 '25
$138MQ4 '25
$53.8MQ1 '26
$47.2MQ2 '26
$36MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

M28 Capital Management 13F FAQ

What does M28 Capital Management own?

M28 Capital Management reported 9 stocks worth $36M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are WVE (47.1%), IVVD (22.3%) and TGTX (13.7%). The table above lists every position in the filing (the top 10 without an account).

What did M28 Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 2 new positions, 0 added to, 0 trimmed and 2 sold out. New positions include WVE and CRIS. It sold all of WVE and CRIS.

When will M28 Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is M28 Capital Management's portfolio worth?

The Q3 2026 filing reports $36M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.